Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Seminars in Oncology|August 1, 1993
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an updateI Brodsky, J C Biggs, J Szer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
Annals of Internal Medicine|December 29, 1998
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune diseaseR A Brodsky, M Petri, B D Smith, et al.
Annals of Internal Medicine|October 2, 2001
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemiaR A Brodsky, L L Sensenbrenner, B D Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2005
Evolutionary regulation of the blind subterranean mole rat, Spalax, revealed by genome-wide gene expressionL I Brodsky, J Jacob-Hirsch, A Avivi, et al.
Seminars in Oncology|August 1, 1993
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2)E A Copelan, J C Biggs, J Szer, et al.
Neurology|June 27, 2002
High-dose cyclophosphamide without stem-cell rescue for refractory CIDPT H Brannagan, A Pradhan, T Heiman-Patterson, et al.
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Autologous stem cell transplantation for acute myeloid leukemia in first remissionC A Linker, C A Ries, L E Damon, et al.
The New England Journal of Medicine|April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant GroupE A Stadtmauer, A O'Neill, L J Goldstein, et al.
Pageof 11